- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2006–2026 · cooperative agreement · U24
Bioconductor: An Open-Source, Open-Development Computing Resource for Genomics
Vincent James Carey · Dana-Farber Cancer Institute · funded by National Institutes of Health
2006–2022 · research · R01
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
Michael J Eck · Dana-Farber Cancer Institute · funded by National Institutes of Health
2006–2021 · research · R01
Integrase Structural Virology
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2006–2026 · cooperative agreement · U24
Bioconductor: An Open-Source, Open-Development Computing Resource for Genomics
Vincent James Carey · Dana-Farber Cancer Institute · funded by National Institutes of Health
2006–2022 · research · R01
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
Michael J Eck · Dana-Farber Cancer Institute · funded by National Institutes of Health
2006–2023 · research · R01
Integrase Structural Virology
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2006–2021 · research · R01
Integrase Structural Virology
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2006–2021 · research · R01
Integrase Structural Virology
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2006–2027 · cooperative agreement · U24
Bioconductor: An Open-Source, Open-Development Computing Resource for Genomics
Vincent James Carey · Dana-Farber Cancer Institute · funded by National Institutes of Health
2005–2024 · research · R01
Functional Genomic Dissection of Refractory Anemia
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
2005–2022 · research · R01
Spatial considerations in neuronal survival signals
Rosalind A. Segal · Dana-Farber Cancer Institute · funded by National Institutes of Health
2005–2023 · research · R01
Functional Genomic Dissection of Refractory Anemia
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
2005–2022 · research · R01
Spatial considerations in neuronal survival signals
Rosalind A. Segal · Dana-Farber Cancer Institute · funded by National Institutes of Health
2005–2023 · research · R01
Functional Genomic Dissection of Refractory Anemia
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
2005–2022 · research · R01
Spatial considerations in neuronal survival signals
Rosalind A. Segal · Dana-Farber Cancer Institute · funded by National Institutes of Health
2005–2023 · research · R01
Functional Genomic Dissection of Refractory Anemia
Benjamin Levine Ebert · Dana-Farber Cancer Institute · funded by National Institutes of Health
2005–2023 · research · R01
Spatial considerations in neuronal survival signals
Rosalind A. Segal · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2027 · research · R01
HIV-1 Preintegration Trafficking and Nuclear Localization
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2024 · program · P50
SPORE in Multiple Myeloma
Kenneth C. Anderson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2022 · research · R01
HIV-1 Preintegration Trafficking and Nuclear Localization
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2024 · program · P50
SPORE in Multiple Myeloma
Kenneth C. Anderson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2024 · program · P50
SPORE in Multiple Myeloma
Kenneth C. Anderson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2024 · program · P50
SPORE in Multiple Myeloma
Kenneth C. Anderson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2022 · research · R01
HIV-1 Preintegration Trafficking and Nuclear Localization
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2025 · research · R01
HIV-1 Preintegration Trafficking and Nuclear Localization
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2022 · research · R01
HIV-1 Preintegration Trafficking and Nuclear Localization
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2025 · program · P50
SPORE in Multiple Myeloma
Kenneth C. Anderson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2022 · research · R01
HIV-1 Preintegration Trafficking and Nuclear Localization
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2022 · research · R01
HIV-1 Preintegration Trafficking and Nuclear Localization
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2027 · research · R01
HIV-1 Preintegration Trafficking and Nuclear Localization
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2027 · research · R01
HIV-1 Preintegration Trafficking and Nuclear Localization
Alan N. Engelman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2025 · program · P50
Targeting AP Nuclease, a Mediator of Genomic Instability in MM
Nikhil C. Munshi · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2025 · program · P50
Biostatistics and Bioinformatics
Giovanni Luigi Parmigiani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2025 · program · P50
Therapeutically Targeting Ubiquitin Receptors in Multiple Myeloma
Kenneth C. Anderson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2025 · program · P50
Career Enhancement Program
Kenneth C. Anderson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2025 · program · P50
Targeting mutated MYD88 signaling in WM
Steven Peter Treon · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2025 · program · P50
Administration, Communication and Planning
Kenneth C. Anderson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2025 · program · P50
Tissue Banking Core
Nikhil C. Munshi · Dana-Farber Cancer Institute · funded by National Institutes of Health
2003–2025 · program · P50
Developmental Research Program
Kenneth C. Anderson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2002–2023 · training · T32
Training in Oncology Population Sciences (TOPS)
Nancy L Keating · Dana-Farber Cancer Institute · funded by National Institutes of Health
